Literature DB >> 8258712

Role of adjuvants in the modulation of antibody isotype, specificity, and induction of protection by whole blood-stage Plasmodium yoelii vaccines.

T L ten Hagen1, A J Sulzer, M R Kidd, A A Lal, R L Hunter.   

Abstract

Mice were immunized with whole killed blood stage Plasmodium yoelii parasites in 15 adjuvant formulations then boosted and challenged with parasitized blood. Five of six groups immunized with the Ag in oil-in-water emulsions or formulations without oil were protected. Formulations that induced protection contained saponin, pertussis, copolymer P1004, and detoxified RaLPS. In contrast, none of nine groups of animals immunized with Ag in water-in-oil emulsions were protected. Ineffective adjuvants included CFA and water-in-squalene emulsions with copolymer L141 plus detoxified RaLPS, dimethyldioctadecyl ammonium bromide, and mycobacterial cell wall skeletons. Antibody was measured by ELISA against disrupted parasites and by indirect fluorescent antibody (immunofluorescence) using intact parasites. Protection was associated with antibody of the IgG2a isotype detected by immunofluorescence but not with other isotypes detected by immunofluorescence or any type antibody detected by ELISA. The water-in-oil adjuvants induced high titers by ELISA but low titers by immunofluorescence. These results, together with Western blot analyses, suggested that adjuvant vehicles control the specificity of antibody and that this, in turn, is essential for induction of protective immune responses in this model.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8258712

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Influence of adjuvants on protection induced by a recombinant fusion protein against malarial infection.

Authors:  T M Daly; C A Long
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Partial protection against Plasmodium vivax blood-stage infection in Saimiri monkeys by immunization with a recombinant C-terminal fragment of merozoite surface protein 1 in block copolymer adjuvant.

Authors:  C Yang; W E Collins; J S Sullivan; D C Kaslow; L Xiao; A A Lal
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

3.  The dichotomy (generation of MAbs with functional heterogeneity) in antimalarial immune response in vaccinated/protected mice: a new concept in our understanding of the protective immune mechanisms in malaria.

Authors:  Prati Pal Singh; Bhanu Prakash
Journal:  Hum Vaccin Immunother       Date:  2014-03-14       Impact factor: 3.452

4.  Humoral and cell-mediated immunity to the Plasmodium falciparum ring-infected erythrocyte surface antigen in an adult population exposed to highly endemic malaria.

Authors:  H P Beck; I Felger; B Genton; N Alexander; F al-Yaman; R F Anders; M Alpers
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

5.  Protective immunity against Plasmodium yoelii malaria induced by immunization with particulate blood-stage antigens.

Authors:  J M Burns; P D Dunn; D M Russo
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

6.  Pathways for potentiation of immunogenicity during adjuvant-assisted immunizations with Plasmodium falciparum major merozoite surface protein 1.

Authors:  G S Hui; C N Hashimoto
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

7.  Transmission blockade of Plasmodium falciparum malaria by anti-Pfs230-specific antibodies is isotype dependent.

Authors:  W Roeffen; F Geeraedts; W Eling; P Beckers; B Wizel; N Kumar; T Lensen; R Sauerwein
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

8.  Induction of opsonizing antibodies after injection of recombinant Plasmodium falciparum vaccine candidate antigens in preimmune Saimiri sciureus monkeys.

Authors:  R Perraut; O Mercereau-Puijalon; D Mattei; E Bourreau; O Garraud; B Bonnemains; L Pereia de Silva; J C Michel
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

9.  Plasmodium vivax promiscuous T-helper epitopes defined and evaluated as linear peptide chimera immunogens.

Authors:  Ivette Caro-Aguilar; Alexandra Rodríguez; J Mauricio Calvo-Calle; Fanny Guzmán; Patricia De la Vega; Manuel Elkin Patarroyo; Mary R Galinski; Alberto Moreno
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

10.  Protective immunization with a novel membrane protein of Plasmodium yoelii-infected erythrocytes.

Authors:  J M Burns; E K Adeeku; P D Dunn
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.